BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HSK47388 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HSK47388\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07158268-64@assetmemo.bio
DTSTAMP:20261121T005716Z
DTSTART;VALUE=DATE:20261220
DTEND;VALUE=DATE:20261221
SUMMARY:HSK47388: Phase 2 readout est. (NCT07158268)
DESCRIPTION:HSK47388\, phase 2\, Psoriasis.\nStudy: A Phase 2 Study of HSK4
 7388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate
 -to-Severe Plaque Psoriasis\nEstimated primary completion: 20 December 202
 6. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/hsk47388#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT07158268
URL:https://assetmemo.bio/drug/hsk47388#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07335055-64@assetmemo.bio
DTSTAMP:20261121T005716Z
DTSTART;VALUE=DATE:20271015
DTEND;VALUE=DATE:20271016
SUMMARY:HSK47388: Phase 2 readout est. (NCT07335055)
DESCRIPTION:HSK47388\, phase 2\, Ulcerative Colitis.\nStudy: A Study for HS
 K47388 in Participants With Ulcerative Colitis\nEstimated primary completi
 on: 15 October 2027. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 hsk47388#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT07335055
URL:https://assetmemo.bio/drug/hsk47388#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
